Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Provention Bio
Provention Bio
(PRVB)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tzield
Teplizumab
2022-11-17
Type 1 diabetes mellitus
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Teplizumab
neoplasms
,
intestinal neoplasms
,
hematologic neoplasms
,
lymphoma
,
psoriasis
,
multiple myeloma
,
down syndrome
,
philadelphia chromosome
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
non-hodgkin lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
hodgkin disease
,
myelomonocytic leukemia juvenile
,
paroxysmal hemoglobinuria
,
hemoglobinuria
,
uveal neoplasms
,
uveal melanoma
,
psoriatic arthritis
,
arthritis
,
hypoglycemia
,
glucose intolerance
,
islets of langerhans transplantation
,
homologous transplantation
,
experimental diabetes mellitus
,
neuroblastoma
,
graft vs host disease
,
mycosis fungoides
,
cytokine release syndrome
,
precursor cell lymphoblastic leukemia-lymphoma
,
burkitt lymphoma
,
biphenotypic leukemia acute
,
precursor b-cell lymphoblastic leukemia-lymphoma
,
melanoma
,
central nervous system neoplasms
,
type 1 diabetes mellitus
,
diabetes mellitus
Cilmostim
neoplasms
,
brain neoplasms
,
glioblastoma
,
neuroblastoma
,
glioma
,
osteosarcoma
,
medulloblastoma
,
rhabdoid tumor
,
ependymoma
,
ewing sarcoma
,
rhabdomyosarcoma
,
diffuse intrinsic pontine glioma
,
recurrence
,
breast neoplasms
,
small cell lung carcinoma
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
congenital abnormalities
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
refractory anemia with excess of blasts
,
erythroblastic leukemia acute
EDICOTINIB
crohn disease
Globulin, immune
myeloid leukemia acute
,
guillain-barre syndrome
,
multiple sclerosis
,
neuromyelitis optica
,
optic neuritis
,
myasthenia gravis
,
chronic inflammatory demyelinating polyradiculoneuropathy
PRV-3279
healthy volunteers/patients
,
systemic lupus erythematosus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use